Nicholas Dixon Hastie (born 1947) is a British geneticist, and former Director of the MRC Human Genetics Unit at the University of Edinburgh.
His nomination reads Distinguished for his original and varied contributions to mammalian developmental genetics, genome organisation and gene expression.
His early work established the abundance of messenger RNAs during mouse development, and led to the cloning of several genes that are expressed specifically in the liver.
Nick Hastie's current work is focused on human developmental mutations, notably Wilm's tumour and Aniridia.
He continues to make incisive contributions to our understanding of the role of WT1, the candidate Wilm's Tumour gene, in development of the kidney and gonad.